IMPROVE-2 Trial: A New Treatment Approach for mCRC
The IMPROVE-2 trial is exploring a new way to treat metastatic colorectal cancer (mCRC) by comparing intermittent versus continuous use of Panitumu...
Educational Programme on Metastatic Pancreatic Cancer Now Available
Metastatic pancreatic ductal adenocarcinoma (mPDAC) is an aggressive and often late-diagnosed cancer with poor prognoses. Early detection remains c...
Advancing Rare Cancer Care: DiCE at the EURACAN Board Meeting
On the 7th and the 8th of November, Laura Urena from Digestive Cancers Europe (DiCE) and a member of EURACAN Patient Advocacy Group (EPAG), partici...
Help Shape the Future of Gastric Cancer Screening in Europe
The TOGAS consortium invites you to participate in a survey on gastric cancer screening. TOGAS is an EU co-funded project exploring the implementat...
DiCE at ESMO 2024
Earlier this month, part of the DiCE Medical and Scientific Team attended the ESMO (European Society for Medical Oncology) Congress 2024 in Barcelo...
DiCE Attends the TOGAS EU Project Consortium Meeting and Conference
Zorana Maravic, our CEO, and Ana Martins participated in the TOGAS Consortium Meeting and TOGAS Conference on 11-12 September at Fundação Eng. An...
DiCE Attends The Horizon Europe Cancer Mission ‘Diagnosis and Treatment’ Cluster Meeting
On September 12th in sunny Barcelona, DiCE, a member of the SAGITTARIUS EU Project, participated in the Horizon Europe Cancer Mission’s ‘Diagno...
DiCE Elevates Patient Advocacy Skills at WECAN Academy in Barcelona
Digestive Cancers Europe (DiCE) had the incredible opportunity to attend the WECAN Academy in the sunny city of Barcelona. Our goal at DiCE is to e...
PerMICCion: A Study on Transforming Colorectal Cancer Prevention and Treatment through Gut Microbiome Research
A groundbreaking study in Germany, known as PerMICCion, is investigating how understanding the microorganisms in our gut, known as the gut microbio...
Lynch Syndrome and the Challenge of Getting a Diagnosis
Lynch Syndrome, also known as hereditary nonpolyposis colorectal cancer (HNPCC), is a hereditary condition characterised by a high risk of various ...